ADGRE5

Across TCGA pan-cancer cohorts, ADGRE5 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of ADGRE5’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where ADGRE5 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types ADGRE5 is over-expressed in tumor, although a few such as LSCC show the opposite, repressed pattern.

HNSC, COAD, and PDAC are the cancer types where ADGRE5 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ADGRE5 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	IV	+0.349	<.001	8	view →
COAD	Male	All	+0.178	<.001	8	view →
PDAC	Female	All	+0.491	<.001	7	view →
CCRCC	All	All	+0.279	<.001	6	view →
LSCC	All	All	−0.137	.001	6	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

ADGRE5–HNSC

Open the HNSC breakdown →